Kristina A. Dudova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kristina A. Dudova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Nikolai Nikolaevich Rukhliada
Saint Petersburg State Pediatric Medical University
3 shared publications - A. N. Taits
Saint Petersburg State Pediatric Medical University
1 shared publication Aleksandra D. Somova
St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation
1 shared publication- Anna N. Taits
Saint Petersburg State Pediatric Medical University
1 shared publication - Anna Nikolaevna Taits
St. Petersburg State Pediatric Medical University
1 shared publication - Irina N. Vorobtsova
Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia
1 shared publication
Latest Publications
- Open Access
- 24 September 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (3) , 255-259
Surgical management of cystic adenomyosis (adenomyoma) in a 17-year-old female patient: A clinical case
Adenomyosis is a common form of endometriosis that affects fertility and is one of the leading causes of dysmenorrhea. It is typical for women aged 35–50. The most common form is diffuse adenomyosis, while focal adenomyosis, a cystic variant, is very rare, especially in patients younger than 30. The main diagnostic methods are ultrasonic examination and magnetic resonance imaging. The article presents a rare clinical case of cystic juvenile adenomyosis in a 17-year-old adolescent girl with severe primary dysmenorrhea who underwent organ-sparing surgical treatment to preserve fertility and eliminate pain. Pathohistological examination confirmed the cystic form of adenomyosis. Forty days after the surgery, painless menstruation occurred; thus, complete pain relief without hormone therapy was achieved.
- 24 September 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (3) , 255-259
Open AccessSurgical management of cystic adenomyosis (adenomyoma) in a 17-year-old female patient: A clinical case
Adenomyosis is a common form of endometriosis that affects fertility and is one of the leading causes of dysmenorrhea. It is typical for women aged 35–50. The most common form is diffuse adenomyosis, while focal adenomyosis, a cystic variant, is very rare, especially in patients younger than 30. The main diagnostic methods are ultrasonic examination and magnetic resonance imaging. The article presents a rare clinical case of cystic juvenile adenomyosis in a 17-year-old adolescent girl with severe primary dysmenorrhea who underwent organ-sparing surgical treatment to preserve fertility and eliminate pain. Pathohistological examination confirmed the cystic form of adenomyosis. Forty days after the surgery, painless menstruation occurred; thus, complete pain relief without hormone therapy was achieved.
- Open Access
- 28 February 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (1) , 37-43
Efficacy of dienogest (Zafrilla) in the treatment of endometriosis: A literature review using meta-analysis tools
Background. Various forms of endometrioid disease affect 7–10% of women of reproductive age and are an important factor in reducing fertility and quality of life. The basis of modern comprehensive therapy is surgery and hormonal agents. Aim. To conduct a meta-analysis of the literature on using dienogest (Zafrilla) for treating pain in endometriosis. Materials and methods. The review and meta-analysis were conducted according to the guidelines of the Cochrane Society and in compliance with the recommendations for systematic reviews and meta-analyses. Data sources for the meta-analysis include publications in the PubMed database between 1997 and February 2024 and relevant research articles in Russian mentioning Zafrilla. Keywords such as "dienogest," "endometriosis surgery," "endometriosis treatment," and "endometriosis" were used to identify relevant studies. The main criterion for the primary assessment was pain relief; the additional one was endometrioma and/or pain recurrence, which indicated a disease relapse. For the meta-analysis, studies mentioning Zafrilla were selected. The study protocol is registered online in the International Prospective Registry of Systematic Reviews (CRD3034892022). Results. Based on the analyzed results of previously published studies, it was found that Zafrilla's effectiveness significantly exceeded placebo and (in some studies) was similar to that of the gonadotropin-releasing hormone agonist in reducing the severity and frequency of pain and relapse after surgery for infiltrative endometriosis and endometriomas. The weighted mean difference with the 95% confidence interval was 1.20 in reducing the pain severity and 1.17 in reducing the number of clinical and morphological relapses in endometriomas and infiltrative endometriosis. The magnitude of the effect for spontaneous pregnancy after surgery and/or endometriosis monotherapy with Zafrilla was 0.9 (relative risk with 95% confidence interval). Conclusion. Our study showed that in many medical institutions where Zafrilla was used for endometriosis both alone and with surgery, clinical improvement was achieved in improving clinical manifestations and significantly reducing the disease recurrence rate. The reduction in endometrioma diameters during non-surgical therapy with Zafrilla without surgery in the study by R. Malik et al. shows the possibilities of modern hormonal drugs and narrows the indications for surgery, allowing the preservation of ovarian reserve along with improving patients' quality of life. Dienogest (Zafrilla) was proven to be effective in pain treatment and prevention of pain recurrence after surgical treatment of endometriosis.
- 28 February 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (1) , 37-43
Open AccessEfficacy of dienogest (Zafrilla) in the treatment of endometriosis: A literature review using meta-analysis tools
Background. Various forms of endometrioid disease affect 7–10% of women of reproductive age and are an important factor in reducing fertility and quality of life. The basis of modern comprehensive therapy is surgery and hormonal agents. Aim. To conduct a meta-analysis of the literature on using dienogest (Zafrilla) for treating pain in endometriosis. Materials and methods. The review and meta-analysis were conducted according to the guidelines of the Cochrane Society and in compliance with the recommendations for systematic reviews and meta-analyses. Data sources for the meta-analysis include publications in the PubMed database between 1997 and February 2024 and relevant research articles in Russian mentioning Zafrilla. Keywords such as "dienogest," "endometriosis surgery," "endometriosis treatment," and "endometriosis" were used to identify relevant studies. The main criterion for the primary assessment was pain relief; the additional one was endometrioma and/or pain recurrence, which indicated a disease relapse. For the meta-analysis, studies mentioning Zafrilla were selected. The study protocol is registered online in the International Prospective Registry of Systematic Reviews (CRD3034892022). Results. Based on the analyzed results of previously published studies, it was found that Zafrilla's effectiveness significantly exceeded placebo and (in some studies) was similar to that of the gonadotropin-releasing hormone agonist in reducing the severity and frequency of pain and relapse after surgery for infiltrative endometriosis and endometriomas. The weighted mean difference with the 95% confidence interval was 1.20 in reducing the pain severity and 1.17 in reducing the number of clinical and morphological relapses in endometriomas and infiltrative endometriosis. The magnitude of the effect for spontaneous pregnancy after surgery and/or endometriosis monotherapy with Zafrilla was 0.9 (relative risk with 95% confidence interval). Conclusion. Our study showed that in many medical institutions where Zafrilla was used for endometriosis both alone and with surgery, clinical improvement was achieved in improving clinical manifestations and significantly reducing the disease recurrence rate. The reduction in endometrioma diameters during non-surgical therapy with Zafrilla without surgery in the study by R. Malik et al. shows the possibilities of modern hormonal drugs and narrows the indications for surgery, allowing the preservation of ovarian reserve along with improving patients' quality of life. Dienogest (Zafrilla) was proven to be effective in pain treatment and prevention of pain recurrence after surgical treatment of endometriosis.
- 30 December 2021
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 10 (4)
The Estimation Of The Quantity And Quality Of Oocytes And Embryos In The IVF Protocols In Women With Uterine Fibroids With And Without Surgical Treatment
Myoma periodically leads to infertility by causing impaired blood flow, aseptic inflammation in the endometrium, increased uterine contractility, impaired sperm migration with cerviсal myoma nodes and obstruction of the proximal fallopian tubes. Objective — The estimation of the quantity and quality of oocytes and embryos in the IVF (in vitro fertilization) protocols in women with uterine fibroids with and without surgical treatment. Material and Methods — The retrospective study included 37 IVF cycles from 37 patients that had infertility combined with myoma. The Group 1 patients were subjected to the IVF procedure without previous treatment of the myoma, while the Group 2 patients were subjected to IVF after myomectomy. Results — The total quantity of oocytes and the percentage of mature (MII) oocytes obtained during the ovarian puncture of the patients in the compared groups were slightly higher in the group without surgical treatment (p>0.05). Any significant differences in the frequency of formation of high-quality embryos (р=0.43) and good-quality embryos (р=0.22) between the groups were not obtained. The number of embryos suitable for embryo transfer to the uterine cavity and/or cryopreservation in the women with myomectomy was 9% higher than the one in the group without surgical treatment. Conclusion — Surgical treatment of uterine fibroids does not significantly affect the quantity and quality of oocytes and embryos obtained in the IVF procedure.
- 30 December 2021
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 10 (4)
The Estimation Of The Quantity And Quality Of Oocytes And Embryos In The IVF Protocols In Women With Uterine Fibroids With And Without Surgical Treatment
Myoma periodically leads to infertility by causing impaired blood flow, aseptic inflammation in the endometrium, increased uterine contractility, impaired sperm migration with cerviсal myoma nodes and obstruction of the proximal fallopian tubes. Objective — The estimation of the quantity and quality of oocytes and embryos in the IVF (in vitro fertilization) protocols in women with uterine fibroids with and without surgical treatment. Material and Methods — The retrospective study included 37 IVF cycles from 37 patients that had infertility combined with myoma. The Group 1 patients were subjected to the IVF procedure without previous treatment of the myoma, while the Group 2 patients were subjected to IVF after myomectomy. Results — The total quantity of oocytes and the percentage of mature (MII) oocytes obtained during the ovarian puncture of the patients in the compared groups were slightly higher in the group without surgical treatment (p>0.05). Any significant differences in the frequency of formation of high-quality embryos (р=0.43) and good-quality embryos (р=0.22) between the groups were not obtained. The number of embryos suitable for embryo transfer to the uterine cavity and/or cryopreservation in the women with myomectomy was 9% higher than the one in the group without surgical treatment. Conclusion — Surgical treatment of uterine fibroids does not significantly affect the quantity and quality of oocytes and embryos obtained in the IVF procedure.
- Open Access
- 15 December 2019
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 10 (1) , 91-99
Contemporary concepts of uterine fibroids’ pathogenesis
Uterine myoma is the most common benign tumor among women which affects mainly those of reproductive age. Moreover, the frequency of emergence of this pathology in population is growing while the age of patients is steadily decreasing. Despite the enormous prevalence of this disease, its pathogenesis has not been studied properly. This article is concerned with an analysis of publications devoted to the study of the mechanisms of growth and development of uterine fibroids, it provides some data on the role of various factors in its extension. The article concerns the most popular concepts of the pathogenesis of this disease according to which the illness may be caused by increased levels of sex hormones (estrogens and progestins), enhanced expression of their receptors, impaired apoptosis, the effect of growth factors (e. g. epidermal growth factor, heparin-binding epidermal growth factor, acid and basic fibroblast growth factors, vascular endothelial growth factor, insulin-like growth factor, platelet-derived growth factor, transforming growth factor-β, activin, myostatin), abnormal deposition extracellular matrix, genetic (chromosomal aberration and various MED12 gene defect) and epigenetic mechanisms (such as action microRNA), circulatory disorders and impairment of cell differentiation from a population of accessory stem cells. However, it is noted that the pathogenesis of this pathology requires further detailed study, as the understanding of the processes leading to its development could greatly contribute to the improvement of the tactics of treatment and possibly allow to elaborate some preventive measures to avert the development of fibroids.
- 15 December 2019
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 10 (1) , 91-99
Open AccessContemporary concepts of uterine fibroids’ pathogenesis
Uterine myoma is the most common benign tumor among women which affects mainly those of reproductive age. Moreover, the frequency of emergence of this pathology in population is growing while the age of patients is steadily decreasing. Despite the enormous prevalence of this disease, its pathogenesis has not been studied properly. This article is concerned with an analysis of publications devoted to the study of the mechanisms of growth and development of uterine fibroids, it provides some data on the role of various factors in its extension. The article concerns the most popular concepts of the pathogenesis of this disease according to which the illness may be caused by increased levels of sex hormones (estrogens and progestins), enhanced expression of their receptors, impaired apoptosis, the effect of growth factors (e. g. epidermal growth factor, heparin-binding epidermal growth factor, acid and basic fibroblast growth factors, vascular endothelial growth factor, insulin-like growth factor, platelet-derived growth factor, transforming growth factor-β, activin, myostatin), abnormal deposition extracellular matrix, genetic (chromosomal aberration and various MED12 gene defect) and epigenetic mechanisms (such as action microRNA), circulatory disorders and impairment of cell differentiation from a population of accessory stem cells. However, it is noted that the pathogenesis of this pathology requires further detailed study, as the understanding of the processes leading to its development could greatly contribute to the improvement of the tactics of treatment and possibly allow to elaborate some preventive measures to avert the development of fibroids.